These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37001272)

  • 21. Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma.
    Chen M; Ma P; Zhang Y; Wang D; Yu Z; Fu Y; Zhao X; Wang M; Zhuang G; Jing Y
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway.
    Zou W; Wang X; Xia X; Zhang T; Nie M; Xiong J; Fang X
    Biochem Biophys Res Commun; 2024 Jan; 692():149338. PubMed ID: 38043156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol protects against deoxynivalenol-induced ferroptosis in HepG2 cells.
    Wang P; Yao Q; Zhu D; Yang X; Chen Q; Lu Q; Liu A
    Toxicology; 2023 Aug; 494():153589. PubMed ID: 37419272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis.
    Huang L; Xie T; Zhao F; Feng Y; Zhu H; Tang L; Han X; Shi Y
    Dis Markers; 2022; 2022():6512300. PubMed ID: 36317140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survival model for prognostic prediction based on ferroptosis-associated genes and the association with immune infiltration in lung squamous cell carcinoma.
    Lu Y; Yang H; Cao Y; Wang Y; Wu M; He B; Xu J; Su Z; Luo W; Liu Y; Hu W
    PLoS One; 2023; 18(3):e0282888. PubMed ID: 36928232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of CHRNA6 in the Immune Response in Lung Squamous Cell Carcinoma and its Potential as a Drug Target for the Disease.
    Zhang F; Zhang M; Yuan X; Tao Y; Wang J
    Curr Pharm Des; 2023; 29(26):2091-2100. PubMed ID: 37680128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of SLC2A1 as a predictive biomarker for survival and response to immunotherapy in lung squamous cell carcinoma.
    Hao B; Dong H; Xiong R; Song C; Xu C; Li N; Geng Q
    Comput Biol Med; 2024 Mar; 171():108183. PubMed ID: 38422959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
    BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of Osteopontin and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) for potential immunotherapeutic significance of in lung squamous cell carcinoma.
    Shan G; Meihe L; Minchao K; Rui Z; Xiaopeng W; Guangjian Z; Jin Z
    Int Immunopharmacol; 2022 Jun; 107():108715. PubMed ID: 35334357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.
    Jiang T; Shi J; Dong Z; Hou L; Zhao C; Li X; Mao B; Zhu W; Guo X; Zhang H; He J; Chen X; Su C; Ren S; Wu C; Zhou C
    J Hematol Oncol; 2019 Jul; 12(1):75. PubMed ID: 31299995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma.
    Wang X; Meng Y; Liu C; Yang H; Zhou S
    J Oncol; 2022; 2022():9103259. PubMed ID: 36131791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol attenuates TNBC lung metastasis by down-regulating PD-1 expression on pulmonary T cells and converting macrophages to M1 phenotype in a murine tumor model.
    Han X; Zhao N; Zhu W; Wang J; Liu B; Teng Y
    Cell Immunol; 2021 Oct; 368():104423. PubMed ID: 34399171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis.
    Li T; Tan Y; Ouyang S; He J; Liu L
    Gene; 2022 Jan; 808():145968. PubMed ID: 34530090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma.
    Yu T; Nie FQ; Zhang Q; Yu SK; Zhang ML; Wang Q; Wang EX; Lu KH; Sun M
    Cell Death Dis; 2024 Jan; 15(1):12. PubMed ID: 38182561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer.
    Yang Z; Peng Y; Guo W; Xu J; Li L; Tian H; Li R; Liu L; Tan F; Gao S; He J
    Thorac Cancer; 2021 Jun; 12(11):1743-1751. PubMed ID: 33979899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
    Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K
    J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol attenuated high intensity exercise training-induced inflammation and ferroptosis via Nrf2/FTH1/GPX4 pathway in intestine of mice.
    Xu Z; Sun X; Ding B; Zi M; Ma Y
    Turk J Med Sci; 2023 Apr; 53(2):446-454. PubMed ID: 37476875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.